The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
so physiologically we know that there's a dose curve as you increase the concentration of platelets for example on neovascularization there is a dose-dependent upward curve on that so the higher the platelet concentration the more new of vascularization you're going to get
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
I think that there's a strong correlation between the amount of platelets that you come to the table with and the amount that we can concentrate